Key result
Nitric oxide continues to be a major focus of pharmacological research and clinical interest twenty years after the 1998 Nobel Prize.
Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
Persistent nitric oxide interest signals ongoing priority; leaves open translation to new therapies.
Louis J. Ignarro (2018) studied this question. Nitric oxide continues to be a major focus of pharmacological research and clinical interest twenty years after the 1998 Nobel Prize.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: